°æºÏ´ëÇб³º´¿ø Ç÷°ü±âÇü ½ÉÆ÷Áö¾ö 2021 : 2021-06-12±³À°ÀÏÀÚ : 2021-06-12
±³À°Àå¼Ò : ¿Â¶óÀÎ&¿ÀÇÁ¶óÀÎ º´Çà (*¿ÀÇÁ¶óÀÎ : °æºÏ´ëÇб³ ÀÇ°ú´ëÇÐ µ¿Àε¿ Ä·ÆÛ½º Áß¾Ó°´ç )
±³À°ÁÖÁ¦ :
(¿Â¶óÀÎ&¿ÀÇÁ¶óÀÎ º´Çà) °æºÏ´ëÇб³º´¿ø Ç÷°ü±âÇü ½ÉÆ÷Áö¾ö 2021ÁÖÃÖ±â°ü : °æºÏ´ëÇб³º´¿ø
´ã´çÀÚ : Á¤È£À±
¿¬¶ôó : 053-200-5685
À̸ÞÀÏ :
hy-chung@knu.ac.kr ±³À°Á¾·ù : ¿Ü°ú, ¼Ò¾Æû¼Ò³â°ú, ¼ºÇü¿Ü°ú, ÇǺΰú, ¿µ»óÀÇÇаú, ÇÙÀÇÇаú
Âü¼®¿¹»óÀοø : 70¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
´ë±¸±¤¿ª½Ã±³À°½Ã°£ : 6 ½Ã°£ 20ºÐ
¼¼ºÎ¼ö°·á : 30,000¿ø
ºñ°í *Âü°¡¿¹»óÀοø : ¿ÀÇÁ¶óÀÎ 30¸í, ¿Â¶óÀÎ 40¸í *¼¼ºÎ¼ö°·á : Àü¹®ÀÇ(»çÀü 2¸¸, ÇöÀå 3¸¸)/Àü°øÀÇ(»çÀü 1¸¸, ÇöÀå 2¸¸)
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 06-12 °æºÏ´ëÇб³ ÀÇ°ú´ëÇÐ µ¿Àε¿ Ä·ÆÛ½º Áß¾Ó°´ç 10:00~10:10 Opening remarks Á¤È£À±(°æºÏ´ë ¼ºÇü¿Ü°ú)
±³À°½Ã°£ 06-12 °æºÏ´ëÇб³ ÀÇ°ú´ëÇÐ µ¿Àε¿ Ä·ÆÛ½º Áß¾Ó°´ç 10:10~10:30 Session¥°. Updated Basic concept 1. ISSVA Classification 2018 Á¤È£À±(°æºÏ´ë ¼ºÇü¿Ü°ú)
±³À°½Ã°£ 06-12 °æºÏ´ëÇб³ ÀÇ°ú´ëÇÐ µ¿Àε¿ Ä·ÆÛ½º Áß¾Ó°´ç 10:30~10:50 Session¥°. Updated Basic concept 2. Basic Pathophysiology of vascular anomalies È«Á¾¿ø(¿¬¼¼´ë ¼ºÇü¿Ü°ú)
±³À°½Ã°£ 06-12 °æºÏ´ëÇб³ ÀÇ°ú´ëÇÐ µ¿Àε¿ Ä·ÆÛ½º Áß¾Ó°´ç 10:50~11:10 Session¥°. Updated Basic concept 3. Basic Radiology Guide to Vascular Anomalies ÀÌÁ¾¹Î(°æºÏ´ë ¿µ»óÀÇÇаú)
±³À°½Ã°£ 06-12 °æºÏ´ëÇб³ ÀÇ°ú´ëÇÐ µ¿Àε¿ Ä·ÆÛ½º Áß¾Ó°´ç 11:10~11:27 Session ¥±. Uncommon Tumors – Tufted angioma / Kaposiform hemangioendothelioma 5. Clinical & Pathological Features º¯Áö¿ø(ÀÎÇÏ´ë ÇǺΰú)
±³À°½Ã°£ 06-12 °æºÏ´ëÇб³ ÀÇ°ú´ëÇÐ µ¿Àε¿ Ä·ÆÛ½º Áß¾Ó°´ç 11:27~11:44 Session ¥±. Uncommon Tumors – Tufted angioma / Kaposiform hemangioendothelioma 6. Radiologic Manifestations Â÷Áß±Ù(°æºÏ´ë ¿µ»óÀÇÇаú)
±³À°½Ã°£ 06-12 °æºÏ´ëÇб³ ÀÇ°ú´ëÇÐ µ¿Àε¿ Ä·ÆÛ½º Áß¾Ó°´ç 11:44~12:00 Session ¥±. Uncommon Tumors – Tufted angioma / Kaposiform hemangioendothelioma 7. Medical Therapies ±èÁöÀ±(°æºÏ´ë ¼Ò¾Æû¼Ò³â°ú)
½Ä»ç 06-12 °æºÏ´ëÇб³ ÀÇ°ú´ëÇÐ µ¿Àε¿ Ä·ÆÛ½º Áß¾Ó°´ç 12:00~12:50 Lunch ()
±³À°½Ã°£ 06-12 °æºÏ´ëÇб³ ÀÇ°ú´ëÇÐ µ¿Àε¿ Ä·ÆÛ½º Áß¾Ó°´ç 12:50~13:07 Session ¥². Provisionally unclassified vascular anomalies 1- Angiokeratoma / Verrucous Hemangioma 9. Clinical & Pathological Features À̼®Á¾(°æºÏ´ë ÇǺΰú)
±³À°½Ã°£ 06-12 °æºÏ´ëÇб³ ÀÇ°ú´ëÇÐ µ¿Àε¿ Ä·ÆÛ½º Áß¾Ó°´ç 13:07~13:24 Session ¥². Provisionally unclassified vascular anomalies 1- Angiokeratoma / Verrucous Hemangioma 10. Radiologic Manifestations È«ÁöÈÆ(°æºÏ´ë ¿µ»óÀÇÇаú)
±³À°½Ã°£ 06-12 °æºÏ´ëÇб³ ÀÇ°ú´ëÇÐ µ¿Àε¿ Ä·ÆÛ½º Áß¾Ó°´ç 13:24~13:40 Session ¥². Provisionally unclassified vascular anomalies 1- Angiokeratoma / Verrucous Hemangioma 11. Surgical Management Á¤È£À±(°æºÏ´ë ¼ºÇü¿Ü°ú)
±³À°½Ã°£ 06-12 °æºÏ´ëÇб³ ÀÇ°ú´ëÇÐ µ¿Àε¿ Ä·ÆÛ½º Áß¾Ó°´ç 13:40~13:57 Session ¥³. Provisionally unclassified vascular anomalies 2-Intramuscular LVM(IMLVM)/PTEN (type) hamartoma of soft tissue / ¡°angiomatosis¡± of soft tissue (PHOST) / Fibro adipose vascular anomaly (FAVA) / Intramuscular hemangioma 13. Clinical and Pathological Findings À̼®Á¾(°æºÏ´ë ÇǺΰú)
±³À°½Ã°£ 06-12 °æºÏ´ëÇб³ ÀÇ°ú´ëÇÐ µ¿Àε¿ Ä·ÆÛ½º Áß¾Ó°´ç 13:57~14:14 Session ¥³. Provisionally unclassified vascular anomalies 2-Intramuscular LVM(IMLVM)/PTEN (type) hamartoma of soft tissue / ¡°angiomatosis¡± of soft tissue (PHOST) / Fibro adipose vascular anomaly (FAVA) / Intramuscular hemangioma 14. Radiologic Manifestations ÀÌÁ¾¹Î(°æºÏ´ë ¿µ»óÀÇÇаú)
±³À°½Ã°£ 06-12 °æºÏ´ëÇб³ ÀÇ°ú´ëÇÐ µ¿Àε¿ Ä·ÆÛ½º Áß¾Ó°´ç 14:14~14:30 Session ¥³. Provisionally unclassified vascular anomalies 2-Intramuscular LVM(IMLVM)/PTEN (type) hamartoma of soft tissue / ¡°angiomatosis¡± of soft tissue (PHOST) / Fibro adipose vascular anomaly (FAVA) / Intramuscular hemangioma 15. Management Á¤È£À±(°æºÏ´ë ¼ºÇü¿Ü°ú)
ÈÞ½Ä 06-12 °æºÏ´ëÇб³ ÀÇ°ú´ëÇÐ µ¿Àε¿ Ä·ÆÛ½º Áß¾Ó°´ç 14:30~14:40 Coffee break ()
±³À°½Ã°£ 06-12 °æºÏ´ëÇб³ ÀÇ°ú´ëÇÐ µ¿Àε¿ Ä·ÆÛ½º Áß¾Ó°´ç 14:40~14:53 Session ¥´. Vascular malformations associated with other anomalies – Klippel-Trenaunay syndrome / Parkes Weber syndrome 17. Clinical Features Çã½Â(°æºÏ´ë Ç÷°ü¿Ü°ú)
±³À°½Ã°£ 06-12 °æºÏ´ëÇб³ ÀÇ°ú´ëÇÐ µ¿Àε¿ Ä·ÆÛ½º Áß¾Ó°´ç 14:53~15:06 Session ¥´. Vascular malformations associated with other anomalies – Klippel-Trenaunay syndrome / Parkes Weber syndrome 18. Radiologic Manifestations ÀÌ»ó¿±(°æºÏ´ë ¿µ»óÀÇÇаú)
±³À°½Ã°£ 06-12 °æºÏ´ëÇб³ ÀÇ°ú´ëÇÐ µ¿Àε¿ Ä·ÆÛ½º Áß¾Ó°´ç 15:06~15:20 Session ¥´. Vascular malformations associated with other anomalies – Klippel-Trenaunay syndrome / Parkes Weber syndrome 19. Management ·ùÁ¤¿±(°æºÏ´ë ¼ºÇü¿Ü°ú)
±³À°½Ã°£ 06-12 °æºÏ´ëÇб³ ÀÇ°ú´ëÇÐ µ¿Àε¿ Ä·ÆÛ½º Áß¾Ó°´ç 15:20~15:45 Session ¥µ. Updated Diagnosis & management of vascular anomalies 21. Diagnosis of Vascular Anomalies in Nuclear Medicine ¾Èº´Ã¶(°æºÏ´ë ÇÙÀÇÇаú)
±³À°½Ã°£ 06-12 °æºÏ´ëÇб³ ÀÇ°ú´ëÇÐ µ¿Àε¿ Ä·ÆÛ½º Áß¾Ó°´ç 15:45~16:10 Session ¥µ. Updated Diagnosis & management of vascular anomalies 22. Rehabilitation in Vascular Anomalies ¹ÚÀºÈñ(°æºÏ´ë ÀçÈ°ÀÇÇаú)
±³À°½Ã°£ 06-12 °æºÏ´ëÇб³ ÀÇ°ú´ëÇÐ µ¿Àε¿ Ä·ÆÛ½º Áß¾Ó°´ç 16:10~16:35 Session ¥µ. Updated Diagnosis & management of vascular anomalies 23. Topical Rapamycin (Sirolimus) Treatment ±èÈƼö(ºÎ»ê´ë ÇǺΰú)
±³À°½Ã°£ 06-12 °æºÏ´ëÇб³ ÀÇ°ú´ëÇÐ µ¿Àε¿ Ä·ÆÛ½º Áß¾Ó°´ç 16:35~17:00 Session ¥µ. Updated Diagnosis & management of vascular anomalies 24. Recent Medical Therapies in Vascular Anomalies ÀÓ¿¬Á¤(Ãæ³²´ë ¼Ò¾Æû¼Ò³â°ú)
Åä·Ð 06-12 °æºÏ´ëÇб³ ÀÇ°ú´ëÇÐ µ¿Àε¿ Ä·ÆÛ½º Áß¾Ó°´ç 17:00~17:30 Session ¥¶. Self assessment (Diagnosis & Management) 26. Case presentation & Discussion ()